The tumor suppressor TP53 family members and oncogenic TFs (NFKB1, AP1 and MYC) are thought to play a crucial role in controlling CRC progression, consistent with the observed results in the published TCGA report [20]. This evidence concerns the gene NFKB1 and colorectal carcinoma.